{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:19:21Z","timestamp":1794248361451,"version":"4.9.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003808"],"award-info":[{"award-number":["82003808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602788"],"award-info":[{"award-number":["81602788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118167","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:25:19Z","timestamp":1781565919000},"page":"118167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Targeting the creatine transporter SLC6A8: Mechanisms and emerging therapeutic strategies for multiple diseases"],"prefix":"10.1016","volume":"251","author":[{"given":"Kai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9014-7502","authenticated-orcid":false,"given":"Hongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118167_b0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1113\/jphysiol.2002.026377","article-title":"Human, rat and chicken small intestinal na+ \u2010cl\u2212 \u2010creatine transporter: Functional, molecular characterization and localization","volume":"545","author":"Peral","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2026.118167_b0010","article-title":"Evaluation of SLC6A8 species conservation and the effect of pathogenic variants on creatine transport","volume":"6","author":"Diep","year":"2025","journal-title":"HGG Adv."},{"key":"10.1016\/j.bcp.2026.118167_b0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2015.10.022","article-title":"Creatine biosynthesis and transport in health and disease","volume":"119","author":"Joncquel-Chevalier Curt","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2026.118167_b0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.nbd.2009.10.022","article-title":"Dissociation of AGAT, GAMT and SLC6A8 in CNS: Relevance to creatine deficiency syndromes","volume":"37","author":"Braissant","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2026.118167_b0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jmedgenet-2013-101658","article-title":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","volume":"50","author":"Van De Kamp","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcp.2026.118167_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/422102","article-title":"High prevalence of SLC6A8 deficiency in X-linked mental retardation","volume":"75","author":"Rosenberg","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2026.118167_b0035","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/01.wnl.0000239153.39710.81","article-title":"High frequency of creatine deficiency syndromes in patients with unexplained mental retardation","volume":"67","author":"Lion-Fran\u00e7ois","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2026.118167_b0040","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1016\/j.apsb.2024.07.004","article-title":"Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway","volume":"14","author":"Bao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118167_b0045","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1158\/0008-5472.CAN-25-0301","article-title":"Hypoxia-induced creatine uptake reprograms metabolism to antagonize PARP1-mediated cell death and facilitate tumor progression in hepatocellular carcinoma","volume":"85","author":"Li","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118167_b0050","first-page":"248","article-title":"Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting","volume":"40","author":"Parma","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bcp.2026.118167_b0055","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.118167_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgme.2021.12.005","article-title":"Current and potential new treatment strategies for creatine deficiency syndromes","volume":"135","author":"Fernandes-Pires","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108595","article-title":"Response to therapy of creatine transporter deficiency caused by a hypomorphic variant in SLC6A8","volume":"143","author":"Longo","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/YPG.0000000000000372","article-title":"Arginine, glycine, and creatine supplementation improves symptoms in a female with creatine transporter deficiency","volume":"34","author":"Tauer","year":"2024","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.bcp.2026.118167_b0075","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/brain\/awaf275","article-title":"Connectomic and behavioural alterations in creatine transporter deficiency are partially normalized by gene therapy","author":"Montani","year":"2026","journal-title":"Brain 149"},{"key":"10.1016\/j.bcp.2026.118167_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1118707","article-title":"Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency","volume":"16","author":"Mabondzo","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2026.118167_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.03.015","article-title":"Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome","volume":"161","author":"El-Kasaby","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.118167_b0090","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/acschembio.4c00571","article-title":"Novel corrector for variants of SLC6A8: a therapeutic opportunity for creatine transporter deficiency","volume":"19","author":"Gechijian","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118167_b0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2023.11.013","article-title":"Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth","volume":"36","author":"Rashidi","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0100","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi7511","article-title":"Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels","volume":"7","author":"Kurth","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2026.118167_b0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/molpharm.124.000995","article-title":"Probing the chemical space of guanidino-carboxylic acids to identify the first blockers of the creatine-transporter-1","volume":"106","author":"Farr","year":"2024","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118167_b0110","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1021\/acs.jmedchem.5c02607","article-title":"Carboxylic acid bioisosteres of creatine as novel and selective substrate competitive inhibitors of the creatine transporter SLC6A8","volume":"69","author":"Martinez","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118167_b0115","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.3390\/ijms24043788","article-title":"Taurine and creatine transporters as potential drug targets in cancer therapy","volume":"24","author":"Stary","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118167_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107694","article-title":"X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease","volume":"140","author":"Mejdahl Nielsen","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41421-025-00801-4","article-title":"Transport and inhibition mechanisms of human creatine transporter","volume":"11","author":"Chen","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.bcp.2026.118167_b0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2426135122","article-title":"Structural insights into the substrate uptake and inhibition of the human creatine transporter (hCRT)","volume":"122","author":"Yuan","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2026.118167_b0135","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1016\/S0021-9258(18)52891-X","article-title":"A na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression","volume":"268","author":"Guimbal","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118167_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/abbi.1998.0959","article-title":"Molecular characterization of the human CRT-1 creatine transporter expressed inXenopusOocytes","volume":"361","author":"Dai","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2026.118167_b0145","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.WCB.0000033966.83623.7D","article-title":"The blood\u2013brain barrier creatine transporter is a major pathway for supplying creatine to the brain","volume":"22","author":"Ohtsuki","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0150","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1471-4159.2010.06957.x","article-title":"Functional and immunocytochemical characterization of the creatine transporter in rat hippocampal neurons","volume":"115","author":"Dodd","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2026.118167_b0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2026.118167_b0160","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cne.23667","article-title":"Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity","volume":"523","author":"Lowe","year":"2015","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bcp.2026.118167_b0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1471-4159.2008.05652.x","article-title":"Expression and possible role of creatine transporter in the brain and at the blood\u2010cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant","volume":"107","author":"Tachikawa","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2026.118167_b0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-014-9713-8","article-title":"X\u2010linked creatine transporter deficiency: Clinical aspects and pathophysiology","volume":"37","author":"Van De Kamp","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118167_b0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.neuint.2005.11.021","article-title":"The SLC6 orphans are forming a family of amino acid transporters","volume":"48","author":"Br\u00f6er","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2026.118167_b0180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: Structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118167_b0185","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/s41598-020-63189-z","article-title":"Studies of structural determinants of substrate binding in the creatine transporter (CreaT, SLC6A8) using molecular models","volume":"10","author":"Colas","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118167_b0190","doi-asserted-by":"crossref","first-page":"e4842","DOI":"10.1002\/pro.4842","article-title":"Probing binding and occlusion of substrate in the human creatine transporter\u20101 by computation and mutagenesis","volume":"33","author":"Clarke","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.bcp.2026.118167_b0195","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1038\/s41467-025-62857-w","article-title":"Molecular basis of human taurine transporter uptake and inhibition","volume":"16","author":"Du","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118167_b0200","article-title":"Structural basis for the transport mechanism and cholesterol modulation of the human proline transporter","author":"Zhou","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118167_b0205","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41467-024-48921-x","article-title":"Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118167_b0210","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1021\/acschemneuro.7b00351","article-title":"Pharmacological characterization of [3 H]ATPCA as a substrate for studying the functional role of the betaine\/GABA transporter 1 and the creatine transporter","volume":"9","author":"Al-Khawaja","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bcp.2026.118167_b0215","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/humu.20532","article-title":"Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application","volume":"28","author":"Rosenberg","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2026.118167_b0220","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ymgme.2011.12.022","article-title":"Detection of variants in SLC6A8 and functional analysis of unclassified missense variants","volume":"105","author":"Betsalel","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2009.10.001","article-title":"Na+\/cl\u2212\/creatine transporter activity and expression in rat brain synaptosomes","volume":"165","author":"Peral","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2026.118167_b0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2019.05.022","article-title":"Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy","volume":"71","author":"Braissant","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2026.118167_b0235","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/0008-5472.CAN-21-1301","article-title":"Cyclocreatine suppresses creatine metabolism and impairs prostate cancer progression","volume":"82","author":"Patel","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118167_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.919439","article-title":"Cooperative binding of substrate and ions drives forward cycling of the human creatine transporter-1","volume":"13","author":"Farr","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.118167_b0245","doi-asserted-by":"crossref","first-page":"264","DOI":"10.21037\/atm-20-5984","article-title":"SLC6A8 is involved in the progression of non-small cell lung cancer through the notch signaling pathway","volume":"9","author":"Feng","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118167_b0250","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cmet.2021.03.009","article-title":"Creatine promotes cancer metastasis through activation of Smad2\/3","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0255","first-page":"168","article-title":"SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bcp.2026.118167_b0260","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1021\/mp9000684","article-title":"The orally active antihyperglycemic drug \u03b2-guanidinopropionic acid is transported by the human proton-coupled amino acid transporter hPAT1","volume":"6","author":"Metzner","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2026.118167_b0265","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1111\/bcp.13390","article-title":"The acute effect of beta\u2010guanidinopropionic acid versus creatine or placebo in healthy men (ABC\u2010trial): a randomized controlled first\u2010in\u2010human trial","volume":"83","author":"Karamat","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118167_b0270","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1073\/pnas.252625599","article-title":"AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation","volume":"99","author":"Zong","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2026.118167_b0275","doi-asserted-by":"crossref","first-page":"E1340","DOI":"10.1152\/ajpendo.2001.281.6.E1340","article-title":"Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis","volume":"281","author":"Bergeron","year":"2001","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0280","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.1071163","article-title":"Regulation of mitochondrial biogenesis in skeletal muscle by CaMK","volume":"296","author":"Wu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118167_b0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cmet.2007.01.008","article-title":"Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis","volume":"5","author":"Reznick","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0290","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11357-022-00667-4","article-title":"Age- and time-dependent mitochondrial genotoxic and myopathic effects of beta-guanidinopropionic acid, a creatine analog, on rodent skeletal muscles","volume":"45","author":"Herbst","year":"2023","journal-title":"GeroScience"},{"key":"10.1016\/j.bcp.2026.118167_b0295","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13269","article-title":"Rapamycin\u2010mediated mouse lifespan extension: Late\u2010life dosage regimes with sex\u2010specific effects","volume":"19","author":"Strong","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2026.118167_b0300","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s11064-014-1336-9","article-title":"Pharmacological identification of a guanidine-containing \u03b2-alanine analogue with low micromolar potency and selectivity for the betaine\/GABA transporter 1 (BGT1)","volume":"39","author":"Al-Khawaja","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bcp.2026.118167_b0305","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jpba.2017.07.049","article-title":"Quantification of cyclocreatine in mouse and rat plasma using hydrophilic-interaction ultra-performance liquid chromatography-tandem mass spectrometry","volume":"145","author":"Wang","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bcp.2026.118167_b0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11095-020-2779-0","article-title":"Cyclocreatine transport by SLC6A8, the creatine transporter, in HEK293 cells, a human blood-brain barrier model cell, and CCDSs patient-derived fibroblasts","volume":"37","author":"Uemura","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2026.118167_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104939","article-title":"Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency","volume":"123","author":"Do","year":"2021","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.bcp.2026.118167_b0320","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213687","article-title":"Creatine deficiency disorders","volume":"104","author":"Silverman","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2026.118167_b0325","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209243","article-title":"Des Portes, Clinical characteristics, developmental trajectory, and caregiver burden of patients with creatine transporter deficiency (SLC6A8)","author":"Curie","year":"2024","journal-title":"Neurology 102"},{"key":"10.1016\/j.bcp.2026.118167_b0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2025.10.023","article-title":"Longitudinal characterization of males with X-linked creatine transporter deficiency: final results of a multiyear observational study","volume":"175","author":"Miller","year":"2025","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bcp.2026.118167_b0335","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.hrthm.2025.11.017","article-title":"Prominent U-waves without QT prolongation in X-linked creatine transporter deficiency caused by SLC6A8 variants","volume":"23","author":"Delini\u00e8re","year":"2026","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.bcp.2026.118167_b0340","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.radcr.2022.01.053","article-title":"Case report: Clinical and magnetic resonance spectroscopy presentation of a female severely affected with X-linked creatine transporter deficiency","volume":"17","author":"Morey","year":"2022","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.bcp.2026.118167_b0345","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13023-020-01617-z","article-title":"Urine creatine metabolite panel as a screening test in neurodevelopmental disorders","volume":"15","author":"Bahl","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcp.2026.118167_b0350","article-title":"Creatine transporter deficiency presenting as failure to thrive: a case report of a novel SLC6A8 variant causing a treatable but likely underdiagnosed genetic disorder","volume":"11","author":"Tise","year":"2023","journal-title":"J. Invest. Med. High Impact Case Rep."},{"key":"10.1016\/j.bcp.2026.118167_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2020.588954","article-title":"The creatine transporter unfolded: a knotty premise in the cerebral creatine deficiency syndrome","volume":"12","author":"Farr","year":"2020","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.bcp.2026.118167_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168383","article-title":"Experimental and computational analysis of newly identified pathogenic mutations in the creatine transporter SLC6A8","volume":"436","author":"Ferrada","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.118167_b0365","doi-asserted-by":"crossref","unstructured":"R. Jomura, M. Sawada, Y. Tega, S.-I. Akanuma, M. Tachikawa, K.-I. Hosoya, Molecular mechanism of SLC6A8 dysfunction with c.1699T\u2009>\u2009C (p.S567P) mutation in cerebral creatine deficiency syndromes, Biol. Pharm. Bull. 47 (2024) 187\u2013191. https:\/\/doi.org\/10.1248\/bpb.b23-00586.","DOI":"10.1248\/bpb.b23-00586"},{"key":"10.1016\/j.bcp.2026.118167_b0370","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89317","article-title":"Suggestion of creatine as a new neurotransmitter by approaches ranging from chemical analysis and biochemistry to electrophysiology","volume":"12","author":"Bian","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118167_b0375","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00726-016-2238-8","article-title":"The effects of creatine supplementation on striatal neural progenitor cells depend on developmental stage","volume":"48","author":"Andres","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2026.118167_b0380","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40478-023-01533-w","article-title":"Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency","volume":"11","author":"Ghirardini","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bcp.2026.118167_b0385","doi-asserted-by":"crossref","first-page":"927","DOI":"10.21037\/tp-23-164","article-title":"Fourteen cases of cerebral creatine deficiency syndrome in children: a cohort study in China","volume":"12","author":"Sun","year":"2023","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.bcp.2026.118167_b0390","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/brainsci13101382","article-title":"Diagnosis and treatment of X-linked creatine transporter deficiency: Case report and literature review","volume":"13","author":"Li","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.bcp.2026.118167_b0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319350","article-title":"Gene delivery of AGAT and GAMT boosts creatine levels in creatine transporter deficiency patient fibroblasts","volume":"20","author":"Wells","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118167_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101251","article-title":"Rescue of myocytes and locomotion through AAV2\/9-2YF intracisternal gene therapy in a rat model of creatine transporter deficiency","volume":"32","author":"Fernandes-Pires","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bcp.2026.118167_b0405","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00018-024-05218-y","article-title":"Dodecyl creatine ester therapy: from promise to reality","volume":"81","author":"Mabondzo","year":"2024","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.bcp.2026.118167_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117195","article-title":"Dodecyl creatine ester, a promising treatment to deliver creatine to neurons, achieves pharmacology efficacy in creatine transporter deficiency","volume":"284","author":"Disdier","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118167_b0415","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/pharmaceutics18010080","article-title":"New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification through Dodecyl Creatine Ester for Neuronal Disorders","volume":"18","author":"Benech","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.118167_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106720","article-title":"Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model","volume":"202","author":"Disdier","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2026.118167_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1362497","article-title":"Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring","volume":"18","author":"Broca-Brisson","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2026.118167_b0430","article-title":"Pan-cancer analysis of the oncogenic and immunological role of solute carrier family 6 member 8 (SLC6A8)","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bcp.2026.118167_b0435","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12672-025-02351-3","article-title":"Multiple machine learning algorithms identified SLC6A8 as a diagnostic biomarker of the late stage of hepatocellular carcinoma","volume":"16","author":"Song","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bcp.2026.118167_b0440","article-title":"Long non-coding RNA AL513318.2 as ceRNA binding to hsa-miR-26a-5p upregulates SLC6A8 expression and predicts poor prognosis in non-small lung cancer","volume":"12","author":"Fan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118167_b0445","first-page":"867","article-title":"Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancer","volume":"39","author":"Kuempers","year":"2024","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bcp.2026.118167_b0450","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.845373","article-title":"SLC6A8 is a potential biomarker for poor prognosis in lung adenocarcinoma","volume":"13","author":"Fan","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bcp.2026.118167_b0455","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1002\/1878-0261.70121","article-title":"Multi\u2010omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma","volume":"19","author":"Staaf","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.118167_b0460","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/cancers15041271","article-title":"Comparison of RNA marker panels for circulating tumor cells and evaluation of their prognostic relevance in breast cancer","volume":"15","author":"Welsch","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118167_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116139","article-title":"SLC6A8-mediated creatine uptake suppresses ERK2-FSP1 signaling and induces ferroptosis in colorectal cancer","volume":"44","author":"Zhou","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118167_b0470","article-title":"The role of CAF-derived vitronectin in promoting colorectal cancer progression and immunosuppression","volume":"12","author":"Yu","year":"2025","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"key":"10.1016\/j.bcp.2026.118167_b0475","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cmet.2021.01.018","article-title":"Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer","volume":"33","author":"Maguire","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0480","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1084\/jem.20182044","article-title":"Creatine uptake regulates CD8 T cell antitumor immunity","volume":"216","author":"Di Biase","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118167_b0485","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12168","article-title":"Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia","volume":"10","author":"Peng","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bcp.2026.118167_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110446","article-title":"Creatine transport and creatine kinase activity is required for CD8(+) Tcell immunity","volume":"38","author":"Samborska","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118167_b0495","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2204015","article-title":"CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport","volume":"12","author":"Tian","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2026.118167_b0500","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176956","article-title":"Creatine supplementation enhances anti-tumor immunity by promoting adenosine triphosphate production in macrophages","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118167_b0505","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.immuni.2019.06.007","article-title":"Slc6a8-mediated creatine uptake and accumulation reprogram macrophage polarization via regulating cytokine responses","volume":"51","author":"Ji","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118167_b0510","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2014.12.018","article-title":"Extracellular metabolic energetics can promote cancer progression","volume":"160","author":"Loo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118167_b0515","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1200\/JCO.2022.40.16_suppl.3579","article-title":"Phase 1b study of RGX-202-01, a first-in-class oral inhibitor of the SLC6A8\/CKB pathway, in combination with FOLFIRI and bevacizumab (BEV) in second-line advanced colorectal cancer (CRC)","volume":"40","author":"Hendifar","year":"2022","journal-title":"J. Clin.oncol."},{"key":"10.1016\/j.bcp.2026.118167_b0520","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fphys.2018.00773","article-title":"A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism","volume":"9","author":"Stockebrand","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.118167_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101387","article-title":"Dietary nitrate attenuates high-fat diet-induced obesity via mechanisms involving higher adipocyte respiration and alterations in inflammatory status","volume":"28","author":"Peleli","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.118167_b0530","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202507543","article-title":"CARD9 conveys pancreatic islet sympathetic nervous \u03b22 signals to reshape macrophage creatine metabolism in type 1 diabetes","volume":"13","author":"Yuan","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2026.118167_b0535","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s42255-019-0035-x","article-title":"Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity","volume":"1","author":"Kazak","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.bcp.2026.118167_b0540","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00726-011-0877-3","article-title":"The creatine kinase system and pleiotropic effects of creatine","volume":"40","author":"Wallimann","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2026.118167_b0545","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/nu13041215","article-title":"Role of creatine in the heart: Health and disease","volume":"13","author":"Balestrino","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.118167_b0550","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13382","article-title":"Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation","volume":"5","author":"Santacruz","year":"2017","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.bcp.2026.118167_b0555","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/cvr\/cvs272","article-title":"Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction","volume":"96","author":"Lygate","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2026.118167_b0560","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1161\/CIRCULATIONAHA.105.572990","article-title":"Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: Insights from creatine transporter\u2013overexpressing transgenic mice","volume":"112","author":"Wallis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2026.118167_b0565","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yjmcc.2024.09.007","article-title":"Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity","volume":"196","author":"Zervou","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2026.118167_b0570","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00726-016-2236-x","article-title":"Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms","volume":"48","author":"Zervou","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2026.118167_b0575","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12968-023-00911-6","article-title":"Synergistic effect on cardiac energetics by targeting the creatine kinase system: In vivo application of high-resolution 31P-CMRS in the mouse","volume":"25","author":"Maguire","year":"2023","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bcp.2026.118167_b0580","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/j.gastro.2020.05.033","article-title":"Creatine transporter, reduced in colon tissues from patients with inflammatory bowel diseases, regulates energy balance in intestinal epithelial cells, epithelial integrity, and barrier function","volume":"159","author":"Hall","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118167_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2025.110164","article-title":"Creatine supplementation in largemouth bass (micropterus salmoides) diets: improving intestinal health and alleviating enteritis","volume":"159","author":"Yu","year":"2025","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.bcp.2026.118167_b0590","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/15357597251410843","article-title":"Optimizing gene therapies for creatine transporter deficiency: Correcting by connecting","volume":"26","author":"Lillis","year":"2026","journal-title":"Epilepsy Curr."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:03:23Z","timestamp":1785884603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":118,"alternative-id":["S0006295226005058"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118167","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the creatine transporter SLC6A8: Mechanisms and emerging therapeutic strategies for multiple diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118167"}}